A qualitative improvement program for minimally invasive mitral surgery: technical advancements ameliorate outcome and operative times. Issue 3 (14th February 2023)
- Record Type:
- Journal Article
- Title:
- A qualitative improvement program for minimally invasive mitral surgery: technical advancements ameliorate outcome and operative times. Issue 3 (14th February 2023)
- Main Title:
- A qualitative improvement program for minimally invasive mitral surgery: technical advancements ameliorate outcome and operative times
- Authors:
- Gollmann-Tepeköylü, Can
Nägele, Felix
Höfer, Daniel
Holfeld, Johannes
Hirsch, Jakob
Oezpeker, Cenk Ulvi
Ruttmann-Ulmer, Elfriede
Kilo, Juliane
Hangler, Herbert
Müller, Ludwig
Grimm, Michael
Bonaros, Nikolaos - Abstract:
- Abstract: OBJECTIVES: Minimally invasive mitral valve surgery (MIMVS) has evolved over the last 2 decades. The aim of the study was to identify the impact of era and technical improvements on perioperative outcome after MIMVS. METHODS: A tota of 1000 patients (mean age: 60.8 ± 12.7 years, 60.3% male) underwent video-assisted or totally endoscopic MIMVS between 2001 and 2020 in a single institution. Three technical modalities were introduced during the observed period: (i) 3D visualization, (ii) use of premeasured artificial chordae (PTFE loops) and (iii) preoperative CT scans. Comparisons were made before and after the introduction of technical improvements. RESULTS: A total of 741 patients underwent isolated mitral valve (MV) procedure, whereas 259 received concomitant procedures. These consisted of tricuspid valve repair (208), left atrium ablation (145) and persistent foramen ovale or atrial septum defect (ASD) closure (172). The aetiology was degenerative in 738 (73.8%) patients and functional in 101 patients (10.1%). A total of 900 patients received MV repair (90%), and 100 patients (10%) underwent MV replacement. Perioperative survival was 99.1%, and periprocedural success 93.5% with a periprocedural safety of 96.3%. Improvement in periprocedural safety attributed to the lower rates of postoperative low output ( P = 0.025) and less reoperations for bleeding ( P < 0.001). 3D visualization improved cross-clamp ( P = 0.001) but not cardiopulmonary bypass times. The useAbstract: OBJECTIVES: Minimally invasive mitral valve surgery (MIMVS) has evolved over the last 2 decades. The aim of the study was to identify the impact of era and technical improvements on perioperative outcome after MIMVS. METHODS: A tota of 1000 patients (mean age: 60.8 ± 12.7 years, 60.3% male) underwent video-assisted or totally endoscopic MIMVS between 2001 and 2020 in a single institution. Three technical modalities were introduced during the observed period: (i) 3D visualization, (ii) use of premeasured artificial chordae (PTFE loops) and (iii) preoperative CT scans. Comparisons were made before and after the introduction of technical improvements. RESULTS: A total of 741 patients underwent isolated mitral valve (MV) procedure, whereas 259 received concomitant procedures. These consisted of tricuspid valve repair (208), left atrium ablation (145) and persistent foramen ovale or atrial septum defect (ASD) closure (172). The aetiology was degenerative in 738 (73.8%) patients and functional in 101 patients (10.1%). A total of 900 patients received MV repair (90%), and 100 patients (10%) underwent MV replacement. Perioperative survival was 99.1%, and periprocedural success 93.5% with a periprocedural safety of 96.3%. Improvement in periprocedural safety attributed to the lower rates of postoperative low output ( P = 0.025) and less reoperations for bleeding ( P < 0.001). 3D visualization improved cross-clamp ( P = 0.001) but not cardiopulmonary bypass times. The use of loops and preoperative CT scan both had no impact on periprocedural success or safety but improved cardiopulmonary bypass and cross-clamp times (both P < 0.001). CONCLUSIONS: Increased surgical experience improves safety in MIMVS. Technical improvements are related to increased operative success and decreased operative times in patients undergoing MIMVS. Abstract : Mitral valve (MV) surgery remains the treatment of choice for operable symptomatic patients with MV disease [1, 2]. … (more)
- Is Part Of:
- Interdisciplinary cardiovascular and thoracic surgery. Volume 36:Issue 3(2023)
- Journal:
- Interdisciplinary cardiovascular and thoracic surgery
- Issue:
- Volume 36:Issue 3(2023)
- Issue Display:
- Volume 36, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 36
- Issue:
- 3
- Issue Sort Value:
- 2023-0036-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-02-14
- Subjects:
- Minimally invasive mitral valve surgery -- Technical innovation -- Mitral valve disease
- DOI:
- 10.1093/icvts/ivad030 ↗
- Languages:
- English
- ISSNs:
- 2753-670X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 26696.xml